Contraceptive Technology Update – April 1, 2019
April 1, 2019
View Issues
-
Counseling on Contraceptive Use for Patients With Coexisting Medical Conditions
The American College of Obstetricians and Gynecologists has released a practice bulletin to help providers use scientific evidence to guide women with coexisting medical conditions in making the most effective choices.
-
Providers Can Improve Teen HPV Vaccination Rates
According to a new study, only about 16% of U.S. adolescents have received the complete vaccination against human papillomavirus (HPV) by the time they turn 13 years of age, despite national recommendations for vaccination at ages 11-12.
-
Researchers Investigate Microneedle Skin Patch Technology for Contraception Delivery
Researchers are studying microneedle skin patch technology for providing a long-acting contraceptive method that can be self-administered.
-
FDA Approves New Test for Mycoplasma genitalium
The Food and Drug Administration has approved the first test to help with the diagnosis of Mycoplasma genitalium, a sexually transmitted infection.
-
Trial Underway for Vaginal Ring Device Designed for HIV Prevention
Researchers are evaluating a vaginal ring designed to protect women against both HIV and herpes simplex virus type 2 in a Phase I study. The trial is being conducted by researchers from the National Institutes of Health-funded Microbicide Trials Network at three U.S. sites in Alabama, California, and Pennsylvania.
-
State Policymakers Work Toward and Against a Post-Roe Country